NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/24/2023
Back to search
Official data from USPTO
BELEAF PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
10/24/2023
Trademark type
Combined
Nice classes
3
Filing date
03/22/2021
Registration date
10/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
10/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-03-00
First use in commerce
2020-09-00
Drawing code
3
Owner type
03
Owner location
ALBERTA, CA
Examiner
SCLEIDOROVICH, JOANNA YAEL
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized words "BELEAF PHARMA" within a circle with a flower design element.
Holders and representatives
Holders
BELEAF PHARMA INC.
Representatives
Cheryl A. Clarkin, Esq. ADLER POLLOCK & SHEEHAN, P.C.
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Topical herbal extracts for cosmetic purposes; botanical and herbal preparationscreamslotions and moisturizing gels for the skin
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/21/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/20/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/19/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/19/2023
IUAF
USE AMENDMENT FILED
09/13/2023
EISU
TEAS STATEMENT OF USE RECEIVED
09/13/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2023
PUBO
PUBLISHED FOR OPPOSITION
01/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/17/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/21/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/21/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/18/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/18/2022
CNSL
SUSPENSION LETTER WRITTEN
03/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/28/2021
GNRT
NON-FINAL ACTION E-MAILED
10/28/2021
CNRT
NON-FINAL ACTION WRITTEN
10/28/2021
DOCK
ASSIGNED TO EXAMINER
10/26/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/25/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2021
NWAP
NEW APPLICATION ENTERED
03/25/2021
Continuous trademark protection
Get notified about every new filing that threatens BELEAF PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.